News and Announcements
Reckoon announces North Block Capital as their advisor
- Published September 03, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Reckoon is pleased to announce North Block Capital as their advisor for its global shopping eco-system.
North Block Capital is a London-based investment group for the digital token capital markets that delivers advisory, capital markets and asset management services. North Block Capital manage a fund which principally invests in blockchain technology projects. Historic investments include Blockstack, Origin, Hashgraph and Republic.
Reckoon wants to reinvent and celebrate the spirit of shopping. They are building a blockchain-based, global shopping ecosystem focused primarily on Gen Z and millennials. This will disrupt the current retail market and engage shoppers through the gamification of worldwide shopping. It will provide global reach to local brands and hyper-local exposure to global brands.
Priya Vrat Misra Founder at Reckoon, comments “North Block is helping us on the journey to reach global Shoppers and Brands. Reckoon will benefit immensely from experience of Simon & Charlie to realise our vision”
Simon Wajcenberg, CEO of North Block Capital comments, “ We are delighted to be working with Reckoon. We have been impressed with the Reckoon team and technical expertise. They truly have the vision and capability to disrupt the retail shopping market.”
About Reckoon
Reckoon is a Blockchain-based, One-Stop-Shopping-App, a global shopping ecosystem focused primarily on Gen Z and millennials. This will disrupt the current retail market and engage shoppers through the gamification of worldwide shopping. It will provide global reach to local brands and hyper-local exposure to global brands.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
